Abstract
Ovarian cancer is a leading cause of death from gynecologic cancers in the USA, and early diagnosis can potentially increase 5-year survival rate. Detection of biomarkers derived from hyperplasia of epithelial tissue by enzyme-linked immunosorbent assay (ELISA) proves to be a practical way of early diagnosis of ovarian cancer. However, ELISA is commonly performed in a laboratory setting, and it cannot be used in a clinical setting for on-site consultation. We have shown a microchip ELISA that detects HE4, an ovarian cancer biomarker, from urine using a cell phone integrated with a mobile application for imaging and data analysis. In microchip ELISA, HE4 from urine was first absorbed on the surface; the primary and secondary antibodies were subsequently anchored on the surface via immuno-reaction; and addition of substrate led to color development because of enzymatic labeling. The microchip after color development was imaged using a cell phone, and the color intensity was analyzed by an integrated mobile application. By comparing with an ELISA standard curve, the concentration of HE4 was reported on the cell phone screen. The presented microchip ELISA coupled with a cell phone is portable as opposed to traditional ELISA, and this method can facilitate the detection of ovarian cancer at the point-of-care (POC).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clarke-Pearson DL (2009) Clinical practice. Screening for ovarian cancer. N Engl J Med 361(2):170–177
Visintin I et al (2008) Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res 14(4):1065–1072
Wang S, Xu F, Demirci U (2010) Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol Adv 28(6):770–781
Wang S et al (2013) Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol Adv 31(4):438–449
Wang S et al (2011) Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care. Lab Chip 11(20):3411–3418
Kim YG et al (2009) Quantum dot-based HIV capture and imaging in a microfluidic channel. Biosens Bioelectron 25(1):253–258
Moon S et al (2009) Integrating microfluidics and lensless imaging for point-of-care testing. Biosens Bioelectron 24(11):3208–3214
Hellstrom I et al (2010) Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett 296(1):43–48
Wang S et al (2014) Micro-a-fluidics ELISA for rapid CD4 cell count at the point-of-care. Sci Rep 4:3796
Cramer DW et al (2011) Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) 4(3):365–374
Zhu CS et al (2011) A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) 4(3):375–383
Acknowledgments
We would like to acknowledge the W.H. Coulter Foundation Young Investigator Award, RO1 A1081534, R21 AI087107. This work was supported by the Center for Integration of Medicine and Innovative Technology (CIMIT) under US Army Medical Research Acquisition Activity Cooperative Agreements DAMD17-02-2-0006, W81XWH-07-2-0011, and W81XWH-09-2-0001. And this work was made possible by a research grant that was awarded and administered by the US Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD. We also acknowledge NIH U01 HL065899-08.
Utkan Demirci (UD) is a founder of, and has an equity interest in, DXNow, a company that is developing microfluidic and imaging technologies for point-of-care diagnostic solutions. UD’s interests were reviewed and are managed by the Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Wang, S., Akbas, R., Demirci, U. (2015). Microchip ELISA Coupled with Cell Phone to Detect Ovarian Cancer HE4 Biomarker in Urine. In: Rasooly, A., Herold, K. (eds) Mobile Health Technologies. Methods in Molecular Biology, vol 1256. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2172-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2172-0_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2171-3
Online ISBN: 978-1-4939-2172-0
eBook Packages: Springer Protocols